Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Inovio Pharmaceuticals Net Income 2006-2019 | INO

Inovio Pharmaceuticals net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Inovio Pharmaceuticals Annual Net Income
(Millions of US $)
2018 $-97
2017 $-88
2016 $-74
2015 $-29
2014 $-36
2013 $-66
2012 $-20
2011 $-15
2010 $-18
2009 $-24
2008 $-13
2007 $-11
2006 $-14
2005 $-26
Inovio Pharmaceuticals Quarterly Net Income
(Millions of US $)
Q2 2019 $-29
Q1 2019 $-29
Q4 2018 $-33
Q3 2018 $-25
Q2 2018 $-7
Q1 2018 $-32
Q4 2017 $-22
Q3 2017 $-34
Q2 2017 $-9
Q1 2017 $-23
Q4 2016 $-26
Q3 2016 $-21
Q2 2016 $-19
Q1 2016 $-8
Q4 2015 $-18
Q3 2015 $6
Q2 2015 $-6
Q1 2015 $-11
Q4 2014 $-7
Q3 2014 $-7
Q2 2014 $-11
Q1 2014 $-11
Q4 2013 $-15
Q3 2013 $-31
Q2 2013 $-11
Q1 2013 $-9
Q4 2012 $-1
Q3 2012 $-7
Q2 2012 $-4
Q1 2012 $-8
Q4 2011 $-5
Q3 2011 $-5
Q2 2011 $-3
Q1 2011 $-2
Q4 2010 $-6
Q3 2010 $-1
Q2 2010 $-8
Q1 2010 $-2
Q4 2009 $-7
Q3 2009 $-3
Q2 2009 $-11
Q1 2009 $-3
Q4 2008 $-4
Q3 2008 $-2
Q2 2008 $-4
Q1 2008 $-3
Q4 2007 $-1
Q3 2007 $-3
Q2 2007 $-4
Q1 2007 $-4
Q4 2006 $-8
Q3 2006 $-3
Q2 2006 $-3
Q1 2006
Q4 2005 $-12
Q3 2005 $-3
Q2 2005 $-2
Q1 2005 $-9
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.222B $0.030B
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.735B 13.98
Gilead Sciences (GILD) United States $82.700B 10.16
CSL (CSLLY) Australia $76.695B 0.00
Celgene (CELG) United States $71.547B 11.07
Illumina (ILMN) United States $45.889B 53.92
Vertex Pharmaceuticals (VRTX) United States $45.274B 48.93
Biogen (BIIB) United States $41.696B 7.41
Regeneron Pharmaceuticals (REGN) United States $33.369B 15.15
Alexion Pharmaceuticals (ALXN) United States $23.501B 12.39
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.152B 0.00
Incyte (INCY) United States $16.887B 49.70
Seattle Genetics (SGEN) United States $13.484B 0.00
Exact Sciences (EXAS) United States $12.915B 0.00
Genmab (GNMSF) Denmark $12.585B 70.59
BioMarin Pharmaceutical (BMRN) United States $12.295B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.991B 0.00
Galapagos (GLPG) Belgium $8.891B 0.00
Bio-Techne Corp (TECH) United States $7.603B 52.52
Sarepta Therapeutics (SRPT) United States $6.546B 0.00
QIAGEN (QGEN) Netherlands $6.202B 20.37
Guardant Health (GH) United States $6.106B 0.00
BeiGene (BGNE) Cayman Islands $5.927B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.803B 0.00
Amarin (AMRN) Ireland $5.665B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.257B 13.36
Exelixis (EXEL) United States $5.086B 13.22
Bluebird Bio (BLUE) United States $4.949B 0.00
Reata Pharmaceuticals (RETA) United States $4.754B 0.00
Moderna (MRNA) United States $4.732B 0.00
China Biologic Products (CBPO) China $4.544B 28.37
ARGENX SE-ADR (ARGX) Netherlands $4.438B 0.00
Ascendis Pharma (ASND) Denmark $4.244B 0.00
Medicines (MDCO) United States $4.212B 0.00
Repligen (RGEN) United States $4.082B 79.22
Spark Therapeutics (ONCE) United States $3.813B 0.00
Blueprint Medicines (BPMC) United States $3.659B 0.00
MorphoSys AG (MOR) Germany $3.449B 0.00
Mirati Therapeutics (MRTX) United States $3.083B 0.00
Alkermes (ALKS) Ireland $2.892B 0.00
Emergent Biosolutions (EBS) United States $2.798B 42.04
Immunomedics (IMMU) United States $2.763B 0.00
Genomic Health (GHDX) United States $2.659B 49.87
Genmab (GMAB) Denmark $2.639B 0.00
MyoKardia (MYOK) United States $2.528B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.467B 0.00
Arena Pharmaceuticals (ARNA) United States $2.436B 5.24
Halozyme Therapeutics (HALO) United States $2.325B 0.00
RA PHARMCTL INC (RARX) United States $2.210B 0.00
Acceleron Pharma (XLRN) United States $2.209B 0.00
Myriad Genetics (MYGN) United States $2.203B 23.12
NeoGenomics (NEO) United States $2.103B 112.50
Intercept Pharmaceuticals (ICPT) United States $2.101B 0.00
Amicus Therapeutics (FOLD) United States $2.101B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.075B 0.00
Ligand Pharmaceuticals (LGND) United States $2.050B 25.92
Cambrex (CBM) United States $2.010B 25.40
Zai Lab (ZLAB) China $1.962B 0.00
Akcea Therapeutics (AKCA) United States $1.874B 0.00
UniQure (QURE) Netherlands $1.684B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.583B 0.00
Insmed (INSM) United States $1.559B 0.00
Denali Therapeutics (DNLI) United States $1.442B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.431B 0.00
REGENXBIO (RGNX) United States $1.388B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.357B 0.00
Coherus BioSciences (CHRS) United States $1.318B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.109B 0.00
Zymeworks (ZYME) Canada $1.105B 0.00
Innoviva (INVA) United States $1.103B 3.19
Dicerna Pharmaceuticals (DRNA) United States $1.025B 0.00
Alector (ALEC) United States $1.013B 0.00
Editas Medicine (EDIT) United States $1.004B 0.00
AnaptysBio (ANAB) United States $0.973B 0.00
Sangamo Therapeutics (SGMO) United States $0.972B 0.00
Fate Therapeutics (FATE) United States $0.964B 0.00
Epizyme (EPZM) United States $0.935B 0.00
Zealand Pharma (ZEAL) Denmark $0.877B 9.84
ANI Pharmaceuticals (ANIP) United States $0.870B 14.52
Athenex (ATNX) United States $0.857B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Codexis (CDXS) United States $0.802B 0.00
Anika Therapeutics (ANIK) United States $0.791B 28.00
Pharming Group (PHGUF) Netherlands $0.782B 0.00
Cara Therapeutics (CARA) United States $0.776B 0.00
Twist Bioscience (TWST) United States $0.763B 0.00
WAVE Life Sciences (WVE) Singapore $0.723B 0.00
Principia Biopharma (PRNB) United States $0.722B 373.88
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.721B 26.02
ZIOPHARM Oncology Inc (ZIOP) United States $0.707B 0.00
Cytokineticsorporated (CYTK) United States $0.681B 0.00
Vericel (VCEL) United States $0.669B 0.00
Revance Therapeutics (RVNC) United States $0.647B 0.00
Mesoblast (MESO) Australia $0.598B 0.00
Heska (HSKA) United States $0.576B 74.67
Arvinas (ARVN) United States $0.564B 0.00
Intellia Therapeutics (NTLA) United States $0.555B 0.00
MiMedx (MDXG) United States $0.554B 0.00
GENFIT S.A (GNFT) France $0.545B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.510B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.487B 0.00
PHARMA MAR SA (PHMMF) Spain $0.485B 0.00
Retrophin (RTRX) United States $0.483B 0.00
UROGEN PHARMA (URGN) United States $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
DBV Technologies S.A (DBVT) France $0.460B 0.00
Intra-Cellular Therapies (ITCI) United States $0.454B 0.00
BioDelivery Sciences (BDSI) United States $0.445B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.431B 0.00
Cellectis S.A (CLLS) France $0.429B 0.00
Adverum Biotechnologies (ADVM) United States $0.411B 0.00
Syros Pharmaceuticals (SYRS) United States $0.397B 0.00
Stemline Therapeutics (STML) United States $0.391B 0.00
Bellus Health (BLU) Canada $0.390B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.387B 0.00
Merus (MRUS) Netherlands $0.375B 0.00
Arcus Biosciences (RCUS) United States $0.369B 0.00
Agenus (AGEN) United States $0.363B 0.00
Precision BioSciences (DTIL) United States $0.348B 0.00
Kadmon Holdings (KDMN) United States $0.345B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.340B 0.00
AC Immune SA (ACIU) Switzerland $0.332B 24.55
Prothena (PRTA) Ireland $0.328B 0.00
CytomX Therapeutics (CTMX) United States $0.325B 0.00
Protagonist Therapeutics (PTGX) United States $0.308B 0.00
Gritstone Oncology (GRTS) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.294B 0.00
Kindred Biosciences (KIN) United States $0.294B 0.00
Cel-Sci (CVM) United States $0.291B 0.00
Avid Bioservices (CDMO) United States $0.283B 0.00
Geron (GERN) United States $0.283B 0.00
Theratechnologies (THTX) Canada $0.282B 0.00
Pfenex (PFNX) United States $0.281B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
Scholar Rock Holding (SRRK) United States $0.278B 0.00
Dynavax Technologies (DVAX) United States $0.274B 0.00
PDL BioPharma (PDLI) United States $0.274B 7.06
Biofrontera AG (BFRA) Germany $0.265B 395.33
Puma Biotechnology (PBYI) United States $0.264B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
MannKind (MNKD) United States $0.241B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.228B 0.00
Albireo Pharma (ALBO) United States $0.227B 0.00
Seres Therapeutics (MCRB) United States $0.224B 0.00
OSMOTICA PHARM (OSMT) United States $0.221B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.220B 0.00
Sutro Biopharma (STRO) United States $0.218B 0.00
Sorrento Therapeutics (SRNE) United States $0.215B 0.00
Compugen (CGEN) Israel $0.211B 0.00
Athersys (ATHX) United States $0.208B 0.00
Spero Therapeutics (SPRO) United States $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Kamada (KMDA) Israel $0.203B 7.74
Exicure (XCUR) United States $0.201B 0.00
Palatin Technologies (PTN) United States $0.191B 5.60
Affimed (AFMD) Germany $0.183B 0.00
Dyadic (DYAI) United States $0.181B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.180B 0.00
ChromaDex (CDXC) United States $0.180B 0.00
Clovis Oncology (CLVS) United States $0.175B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.169B 0.00
Senesco Technologies (ELOX) United States $0.167B 0.00
Cue Biopharma (CUE) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Enzo Biochem (ENZ) United States $0.160B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
XOMA (XOMA) United States $0.158B 0.00
Arsanis (XFOR) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Five Prime Therapeutics (FPRX) United States $0.152B 0.00
Alcobra (ARCT) United States $0.151B 0.00
BioTime (LCTX) United States $0.142B 9.49
CorMedix Inc (CRMD) United States $0.134B 0.00
Abeona Therapeutics (ABEO) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.132B 0.00
Emmaus Life Sciences (EMMA) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.130B 0.00
NantKwest (NK) United States $0.124B 0.00
PHASEBIO PHARMA (PHAS) United States $0.123B 0.00
Acorda Therapeutics (ACOR) United States $0.123B 0.00
SESEN BIO, INC (SESN) United States $0.122B 0.00
Novavax (NVAX) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Menlo Therapeutics (MNLO) United States $0.110B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
Aptinyx (APTX) United States $0.108B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.107B 0.00
Strongbridge Biopharma (SBBP) United States $0.107B 4.38
Celyad SA (CYAD) Belgium $0.097B 0.00
OvaScience (MLND) United States $0.096B 0.00
VBI Vaccines (VBIV) United States $0.094B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Trevena (TRVN) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Vaccinex (VCNX) United States $0.083B 0.00
Verastem (VSTM) United States $0.082B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.080B 0.00
Checkpoint Therapeutics (CKPT) United States $0.080B 0.00
Aduro Biotech (ADRO) United States $0.080B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.075B 0.00
Mersana Therapeutics (MRSN) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Curis (CRIS) United States $0.069B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Selecta Biosciences (SELB) United States $0.061B 0.00
Arbutus Biopharma (ABUS) Canada $0.058B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Orgenesis (ORGS) United States $0.057B 20.88
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.056B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.053B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.050B 0.00
Unum Therapeutics (UMRX) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
AIT Therapeutics (XAIR) United States $0.047B 0.00
NewLink Genetics (NLNK) United States $0.047B 0.00
Stellar Biotechnologies (EDSA) Canada $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Oncobiologics (OTLK) United States $0.040B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.039B 0.00
Proteostasis Therapeutics (PTI) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Clearside Biomedical (CLSD) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.90
Alimera Sciences (ALIM) United States $0.028B 0.00
Protalix BioTherapeutics (PLX) Israel $0.027B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
DiaMedica Therapeutics (DMAC) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
IBio (IBIO) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
TrovaGene (TROV) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.003B 0.00